Search Results Search Sort by RelevanceMost Recent Case and Commentary Jan 2021 当医生发现其患者被强制绝育时应如何应对? Rebecca Kluchin(理学博士) AMA J Ethics. 2021;E18-25. doi: 10.1001/amajethics.2021.18. Case and Commentary Jan 2021 How Should a Physician Respond to Discovering Her Patient Has Been Forcibly Sterilized? Rebecca Kluchin, PhD Sterilization requires physicians’ surgical skills. Forced sterilization requires many clinicians’ complicity. AMA J Ethics. 2021;23(1):E18-25. doi: 10.1001/amajethics.2021.18. Medicine and Society Feb 2021 How Can the Experiences of Black Women Living With HIV Inform Equitable and Respectful Reproductive Health Care Delivery? Faith E. Fletcher, PhD, MA, Ndidiamaka Amutah-Onukagha, PhD, MPH, Julie Attys, MPH, and Whitney S. Rice, DrPH, MPH Black women living with HIV contend with injuries of injustice that influence their reproductive lives. AMA J Ethics. 2021;23(2):E156-165. doi: 10.1001/amajethics.2021.156. Medicine and Society Jul 2021 Invisibility of “Gender Dysphoria” Nicolle K. Strand, JD, MBE and Nora L. Jones, PhD Fostering transgender patients’ sense of agency should be a clinical and ethical priority. AMA J Ethics. 2021;23(7):E557-562. doi: 10.1001/amajethics.2021.557. Art of Medicine Jul 2021 Wayfinding Brent R. Carr, MD This charcoal gesture drawing, inspired by a mid-adolescent nonbinary patient, investigates a caregiver’s and patient’s journey from despair to hope. AMA J Ethics. 2021;23(7):E582-583. doi: 10.1001/amajethics.2021.582. History of Medicine Sep 2021 FDA Device Oversight From 1906 to the Present Anna Pisac and Natalia Wilson, MD, MPH A history of device oversight by the US Food and Drug Administration traces regulatory changes in response to injuries caused by Dalkon Shield intrauterine devices. AMA J Ethics. 2021;23(9):E712-720. doi: 10.1001/amajethics.2021.712. Viewpoint Sep 2021 Is the FDA Failing Women? Madris Kinard, MBA and Rita F. Redberg, MD, MSc Many devices in current use were marketed before manufacturers were required to demonstrate safety and effectiveness. AMA J Ethics. 2021;23(9):E750-756. doi: 10.1001/amajethics.2021.750. AMA Code Says Nov 2020 AMA Code of Medical Ethics’ Opinions Related to Risk Management Ethics Scott J. Schweikart, JD, MBE and Deborah M. Eng, MS, MA Ethical dimensions of risk management are illuminated in AMA Code content on discharge planning. AMA J Ethics. 2020;22(11):E940-944. doi: 10.1001/amajethics.2020.940. Health Law Nov 2020 How Hospital Leaders and Risk Managers Can Nurture Ethics-Driven Lawyering Norine A. McGrath, MD, Evan G. DeRenzo, PhD, John K. Kilcullen, MD, JD, MPH, and Jack Schwartz, JD Hospital lawyers’ practices shape risk management operations, influence clinicians’ morale, and affect patient care. AMA J Ethics. 2020;22(11):E933-939. doi: 10.1001/amajethics.2020.933. Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852. Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Next page Next › Last page Last »
Case and Commentary Jan 2021 当医生发现其患者被强制绝育时应如何应对? Rebecca Kluchin(理学博士) AMA J Ethics. 2021;E18-25. doi: 10.1001/amajethics.2021.18.
Case and Commentary Jan 2021 How Should a Physician Respond to Discovering Her Patient Has Been Forcibly Sterilized? Rebecca Kluchin, PhD Sterilization requires physicians’ surgical skills. Forced sterilization requires many clinicians’ complicity. AMA J Ethics. 2021;23(1):E18-25. doi: 10.1001/amajethics.2021.18.
Medicine and Society Feb 2021 How Can the Experiences of Black Women Living With HIV Inform Equitable and Respectful Reproductive Health Care Delivery? Faith E. Fletcher, PhD, MA, Ndidiamaka Amutah-Onukagha, PhD, MPH, Julie Attys, MPH, and Whitney S. Rice, DrPH, MPH Black women living with HIV contend with injuries of injustice that influence their reproductive lives. AMA J Ethics. 2021;23(2):E156-165. doi: 10.1001/amajethics.2021.156.
Medicine and Society Jul 2021 Invisibility of “Gender Dysphoria” Nicolle K. Strand, JD, MBE and Nora L. Jones, PhD Fostering transgender patients’ sense of agency should be a clinical and ethical priority. AMA J Ethics. 2021;23(7):E557-562. doi: 10.1001/amajethics.2021.557.
Art of Medicine Jul 2021 Wayfinding Brent R. Carr, MD This charcoal gesture drawing, inspired by a mid-adolescent nonbinary patient, investigates a caregiver’s and patient’s journey from despair to hope. AMA J Ethics. 2021;23(7):E582-583. doi: 10.1001/amajethics.2021.582.
History of Medicine Sep 2021 FDA Device Oversight From 1906 to the Present Anna Pisac and Natalia Wilson, MD, MPH A history of device oversight by the US Food and Drug Administration traces regulatory changes in response to injuries caused by Dalkon Shield intrauterine devices. AMA J Ethics. 2021;23(9):E712-720. doi: 10.1001/amajethics.2021.712.
Viewpoint Sep 2021 Is the FDA Failing Women? Madris Kinard, MBA and Rita F. Redberg, MD, MSc Many devices in current use were marketed before manufacturers were required to demonstrate safety and effectiveness. AMA J Ethics. 2021;23(9):E750-756. doi: 10.1001/amajethics.2021.750.
AMA Code Says Nov 2020 AMA Code of Medical Ethics’ Opinions Related to Risk Management Ethics Scott J. Schweikart, JD, MBE and Deborah M. Eng, MS, MA Ethical dimensions of risk management are illuminated in AMA Code content on discharge planning. AMA J Ethics. 2020;22(11):E940-944. doi: 10.1001/amajethics.2020.940.
Health Law Nov 2020 How Hospital Leaders and Risk Managers Can Nurture Ethics-Driven Lawyering Norine A. McGrath, MD, Evan G. DeRenzo, PhD, John K. Kilcullen, MD, JD, MPH, and Jack Schwartz, JD Hospital lawyers’ practices shape risk management operations, influence clinicians’ morale, and affect patient care. AMA J Ethics. 2020;22(11):E933-939. doi: 10.1001/amajethics.2020.933.
Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852.